Decibel Therapeutics, Inc. DBTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Decibel Therapeutics, Inc. (DBTX), 포함 23 건 매수 및 20 건 매도. 내부자 매수 총액은 $3.3M 내부자 매도 총액은 $6.91M.

최근 활동이 있는 주요 내부자에는 Mclaughlin Kevin F, Reid Laurence, Kapusta Matthew C. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — DBTX

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2023-09-25	Mclaughlin Kevin F	Director	주식 반환	5,000	$4.78	$23.9K	-
2023-09-25	Reid Laurence	See Remarks	주식 반환	1,072,539	$4.40	$4.72M	-
2023-09-25	Kapusta Matthew C	Director	주식 반환	10,000	$3.34	$33.4K	-
2023-09-25	Finger Alison Cecily	Director	주식 반환	20,000	$6.20	$124K	-
2023-09-25	Carson William H.	Director	주식 반환	20,000	$8.42	$168.4K	-
2023-09-25	Trask Anna	Chief People Officer	주식 반환	137,302	$4.40	$604.13K	-
2023-09-25	Lee John Jui-jen	Chief Development Officer	주식 반환	232,003	$4.40	$1.02M	-
2023-09-25	Nochur Sara	Director	주식 반환	20,000	$6.20	$124K	-
2023-06-13	Mclaughlin Kevin F	Director	RSU 부여	5,000	$4.78	$23.9K	5,000
2023-06-13	Finger Alison Cecily	Director	RSU 부여	5,000	$4.78	$23.9K	5,000
2023-06-13	Carson William H.	Director	RSU 부여	5,000	$4.78	$23.9K	5,000
2023-06-13	Nochur Sara	Director	RSU 부여	5,000	$4.78	$23.9K	5,000
2023-03-19	Kapusta Matthew C	Director	알 수 없음	-	-	-	-
2023-03-19	Kapusta Matthew C	Director	RSU 부여	10,000	$3.34	$33.4K	10,000
2023-03-16	Reid Laurence	See Remarks	RSU 부여	72,000	$3.73	$268.56K	72,000
2023-01-26	Trask Anna	Chief People Officer	RSU 부여	45,000	-	-	45,000
2023-01-26	Lee John Jui-jen	Chief Development Officer	RSU 부여	45,000	-	-	45,000
2022-10-10	Mclaughlin Kevin F	Director	알 수 없음	-	-	-	-
2022-10-10	Mclaughlin Kevin F	Director	RSU 부여	20,000	-	-	20,000
2022-10-07	Murphy James B	Officer	알 수 없음	-	-	-	-
2022-06-17	Thompson Peter A.	10 Percent Owner	RSU 부여	10,000	$2.30	$23K	10,000
2022-06-17	Exter Neil	10 Percent Owner	RSU 부여	10,000	$2.30	$23K	10,000
2022-06-17	Finger Alison Cecily	Director	RSU 부여	10,000	$2.30	$23K	10,000
2022-06-17	Carson William H.	Director	RSU 부여	10,000	$2.30	$23K	10,000
2022-06-17	Nochur Sara	Director	RSU 부여	10,000	-	-	10,000
2022-02-25	Reid Laurence	See Remarks	RSU 부여	187,500	$3.50	$656.25K	187,500
2022-02-25	Trask Anna	See Remarks	RSU 부여	52,500	$3.50	$183.75K	52,500
2022-02-25	Leiderman Elisabeth	Chief Financial Officer	RSU 부여	52,500	$3.50	$183.75K	52,500
2022-02-25	Lee John Jui-jen	Chief Development Officer	RSU 부여	52,500	$3.50	$183.75K	52,500
2022-01-03	Trask Anna	See Remarks	정보 매도	377	$5.03	$1.9K	1,864
2021-12-03	Finger Alison Cecily	Director	알 수 없음	-	-	-	-
2021-12-03	Finger Alison Cecily	Director	RSU 부여	20,000	$6.20	$124K	20,000
2021-12-03	Nochur Sara	Director	알 수 없음	-	-	-	-
2021-12-03	Nochur Sara	Director	RSU 부여	20,000	$6.20	$124K	20,000
2021-12-02	Trask Anna	See Remarks	정보 매도	378	$6.34	$2.39K	2,242
2021-11-03	Trask Anna	See Remarks	정보 매도	378	$8.34	$3.15K	7,533
2021-11-02	Trask Anna	See Remarks	정보 매도	4,913	$8.31	$40.83K	7,911
2021-10-14	Trask Anna	See Remarks	정보 매도	5,364	$7.55	$40.48K	12,824
2021-09-15	Reid Laurence	President and Chief Executive	정보 매수	10,000	$7.64	$76.4K	25,849
2021-08-16	Hu Cynthia W.	Officer	알 수 없음	-	-	-	-
2021-08-16	Hu Cynthia W.	General Counsel	RSU 부여	150,000	$7.37	$1.11M	150,000
2021-06-02	Carson William H.	Director	알 수 없음	-	-	-	-
2021-06-02	Carson William H.	Director	RSU 부여	20,000	$8.42	$168.4K	20,000
2021-02-17	Gv 2016 Gp, L.l.c.	10 Percent Owner	전환 (매도)	5,000,000	-	-	-
2021-02-17	Gv 2017 Gp, L.l.c.	10 Percent Owner	전환 (매도)	6,250,000	-	-	-
2021-02-17	Gv 2019 Gp, L.l.c.	10 Percent Owner	전환 (매도)	4,344,048	-	-	-
2021-02-17	Regeneron Pharmaceuticals, Inc.	10 Percent Owner	전환 (매도)	14,000,000	-	-	-
2021-02-17	Longevity Fund 2 Lp	10 Percent Owner	전환 (매도)	79,143	-	-	-
2021-02-17	Orbimed Advisors Llc	10 Percent Owner	전환 (매도)	1,158,412	-	-	-
2021-02-17	Glaxosmithkline Plc	Director	전환 (매도)	1,737,619	-	-	-